Identification and functional analysis of cytochrome P450 complement in Streptomyces virginiae IBL14 by Zhi-Zhen Li et al.
Li et al. BMC Genomics 2013, 14:130
http://www.biomedcentral.com/1471-2164/14/130RESEARCH ARTICLE Open AccessIdentification and functional analysis of
cytochrome P450 complement in Streptomyces
virginiae IBL14
Zhi-Zhen Li1†, Xiao-Fei Li1†, Wei Yang1, Xiang Dong1, Jie Yu2, Shu-Liang Zhu1, Man Li1, Li Xie1 and Wang-Yu Tong1*Abstract
Background: As well known, both natural and synthetic steroidal compounds are powerful endocrine disrupting
compounds (EDCs) which can cause reproductive toxicity and affect cellular development in mammals and thus
are generally regarded as serious contributors to water pollution. Streptomyces virginiae IBL14 is an effective
degradative strain for many steroidal compounds and can also catalyze the C25 hydroxylation of diosgenin, the
first-ever biotransformation found on the F-ring of diosgenin.
Results: To completely elucidate the hydroxylation function of cytochrome P450 genes (CYPs) found during
biotransformation of steroids by S. virginiae IBL14, the whole genome sequencing of this strain was carried out via
454 Sequencing Systems. The analytical results of BLASTP showed that the strain IBL14 contains 33 CYPs, 7
ferredoxins and 3 ferredoxin reductases in its 8.0 Mb linear chromosome. CYPs from S. virginiae IBL14 are
phylogenetically closed to those of Streptomyces sp. Mg1 and Streptomyces sp. C. One new subfamily was found as
per the fact that the CYP Svu001 in S. virginiae IBL14 shares 66% identity only to that (ZP_05001937, protein
identifer) from Streptomyces sp. Mg1. Further analysis showed that among all of the 33 CYPs in S. virginiae IBL14,
three CYPs are clustered with ferredoxins, one with ferredoxin and ferredoxin reductase and three CYPs with
ATP/GTP binding proteins, four CYPs arranged with transcriptional regulatory genes and one CYP located on the
upstream of an ATP-binding protein and transcriptional regulators as well as four CYPs associated with other
functional genes involved in secondary metabolism and degradation.
Conclusions: These characteristics found in CYPs from S. virginiae IBL14 show that the EXXR motif in the K-helix is
not absolutely conserved in CYP157 family and I-helix not absolutely essential for the CYP structure, too.
Experimental results showed that both CYP Svh01 and CYP Svu022 are two hydroxylases, capable of bioconverting
diosgenone into isonuatigenone and β-estradiol into estriol, respectively.
Keywords: Biotransformation, Cytochrome P450, Ferredoxin, Ferredoxin reductase, Gene sequencing, Secondary
metabolismBackground
Cytochrome P450 (CYP) genes refer to such genes that
encode a superfamily of iron-containing hemoproteins
with a maximum absorption spectrum near 450 nm, often
characterized by conserved Cys residue in hydrophobic
pocket(s) [1]. Most of the ORFs of CYP have three distinct
characteristics used often for their identification and* Correspondence: tongwy@ahu.edu.cn
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reproduction in any medium, provided the oranalysis, i.e., the I-helix of putative CYPs (a highly
conserved threonine involved in oxygen activation), the
conserved EXXR motif located in the K-helix and the
cytochrome P450 cysteine heme-iron ligand signature
motif (GXXXCXG, there are exceptions) [2]. According to
a widely-accepted taxonomy, CYPs within a family share
more than 40% amino acid identity and members of sub-
families share more than 55% amino acid identity [3]. Oc-
casionally, the decision to accept a sequence in a known
family depends greatly on how it clusters on a tree, not so
much on the absolute amino acid identity [4].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(human, animals, plants, fungi, etc.) and prokaryotic
organisms (bacteria, archaea, and even in viruse) [5-8].
They often are monooxygenases involved in oxidation of
a range of endogenous compounds, such as cholesterol,
lipids and steroidal hormones, as well as xenobiotics
such as drugs and toxic chemicals in environment
[9-11]. CYPs catalyse diverse reactions, including C-H
hydroxylation, epoxidation, hetero-atom oxidation, aro-
matic ring oxidation and dealkylation [11-13]. In the
catalytic reaction process of P450 monooxygenase, one
atom of O2 is inserted into substrate while the other is
reduced to H2O. CYP genes responsible for secondary
metabolism are often laid in antibiotic biosynthetic gene
clusters to catalyze stereo- and region- specific reaction
of substrates to related derivatives.
The biotransforming capabilities of bacterial CYPs
have been widely elucidated. P450soy (CYP105D1) from
Streptomyces griseus was involved in the degradation of
a diverse array of complex agrochemicals and environ-
mental pollutants [14]. CYP105C1 from Actinomycete
spp. had the ability to transform benanomicin A into
two derivatives, 10-hydroxybenanomicin A and 11-O
-demethylbenanomicin [15]. The functions of related
CYP107 family members have been reported. CYP107E
from Micromonospora griseorubida was found to govern
the hydroxylation and epoxidization in mycinamicin
biosynthesis [16], P450 Terf (107 L) from Streptomyces
platensis to catalyze hydroxylation of terfenadine
[17] and hydroxylase PikC (107 L1) of Streptomyces
venezuelae to convert narbomycin to picromycin [18].
CYP124 of Mycobacterium tuberculosis demonstrated
omega-hydroxylase activity of relevant methyl-branched
lipids [19]. YbdT (CYP152A) of Bacillus subtilis was
involved in fatty acid beta-hydroxylation [20]. CYP154 of
Nocardia farcinica IFM10152 had the functions of the
O-dealkylation and ortho-hydroxylation of formono-
netin [21] and 154H1 from Clostridium acetobutylicum
performed biocatalytic reactions with different aliphatic
and aromatic substrates [22].
Genome sequencing is an effective way to predict and
annotate all the possible CYPs genes in an organism.
Streptomyces coelicolor A3 (2), a typical strain which is
often used for the study of physiological function and anti-
biotic production, is the first Streptomyces species
sequenced in 2001. Its linear chromosome is 8.7 Mb [23]
which contains 7825 open reading frames (ORFs) with 18
putative CYPs [24]. S. avermitilis, known for producing
the antiparasitic agent avermectin, contains 7600 ORFs
with 33 putative CYPs in the 9 Mb chromosomes [25,26].
The genome of Streptomyces peucetius ATCC27592 with
the size of 8.7 Mb contains 19 putative CYPs [27].
S. virginiae IBL14, isolated from activated sludge for
treatment of waste from a steroidal drug factory, is aneffective degradative strain of various steroidal compounds,
including progesterone, isotestosterone, dihydrotestoster-
one, hydrocortisone, cholesterol and ostrone [28]. To com-
prehensively understand the function of CYPs of S.
virginiae IBL14 in degradation and biotransformation of di-
osgenin, the whole genome sequencing of S. virginiae
IBL14 isolated by our lab was carried out for the first time.
Using in silico technology, we predict and annotate all of
the putative CYPs of S. virginiae IBL14 and analyze these
CYPs evolutionarily and functionally via comparison with
those of other Streptomyces species. Furthermore, functions
and characteristics of CYP genes svh01 and CYP svu022 in
this strain are experimentally identified and analyzed.
Results and discussion
Genome sequencing and CYPs in S. virginiae IBL14
By in silico analysis of newly-sequenced S. virginiae IBL14
8.0 Mb genome, 8288 ORFs are identified and the total
GC content exceeds 70%. The annotated results via
Rpsblast display that there are a total of 33 putative CYPs
in the genome of this strain IBL14, contributing to ap-
proximately 0.4% of all the coding sequences. The number
of CYPs is identical to that in S. avermitili and almost two
times as that in S. coelicolor A3(2) and S. peucetius
ATCC27952 (18 and 19 CYPs, respectively). Such high
level of CYP diversity suggests the high diversity of the
secondary metabolism pathways in S. virginiae IBL14.
The 32 out of 33 putative CYPs of S. virginiae IBL14 be-
long to 13 previously-reported CYP families, i.e., 105 (5),
107 (11), 121 (1), 124 (1), 147 (1), 152 (1), 154 (1), 157 (2),
185 (1), 191 (3), 197 (4), 247(1) and another to an un-
known family, as shown in Table 1. Among the all, the
CYP121A (Svu018), CYP124 (Svu19), CYP147 (Svu020),
CYP152 (Svu021), CYP154H (Svu022), CYP157 (Svu023-
024), CYP185 (Svu025), CYP191 (Svu26-28), CYP197
(Svu017,029-031) and CYP247 (Svu032) are firstly reported
in S. virginiae, and especially, CYP107M, CYP185A and
CYP247A have been found rarely in Streptomycete spp.
The Svu025, Svu026 and Svu029 have lower identity with
other family members (<50%) while others show more
than 63% identity to CYPs of other organisms. It’s worth
noting that the Svu001 presumably belongs to a new CYP
family since no close homologue is found in Genbank ex-
cept that in Streptomyces sp. Mg1 with 66% identity.
Features of CYPs from S. virginiae IBL14
Table 2 displays the three characteristic motifs of CYPs of
S. virginiae IBL14. The critical residues are highlighted
with bold fonts, which are threonine (T) in GXXTT motif
of I-helix, glutamic acid (E) and arginine (R) in EXXR
motif of K-helix and cysteine (C) in the GXXXCXG
heme-binding domain signature, respectively.
From the Table 2, we can find the I-helix is absent in
Svu001(new family), and the I-helix and K-helix missing
Table 1 Putative cytochrome P450s in S. virginiae IBL14 with their closest homologs
IDa Sizeb Best matches in the database
Species Protein identifier CYP family AA overlapd identitye%
Svu001 464 Streptomyces sp. Mg1 ZP_05001937 new 598 66
Photobacterium profundum 3TCK ZP_01217946 113 25
Svu002 361 Streptomyces virginiae ABR68806 105 L 134 100
Streptomyces clavuligerus ATCC 27064 ZP_06769587 93.2 66
Svu003 439 Streptomyces venezuelae ATCC 10712 CCA59424 105C 608 77
Streptomyces cattleya NRRL 8057 YP_004920090 105C 553 70
Svu004 398 Streptomyces virginiae ABR68806 105 L 794 99
Streptomyces sp. ACT50-5 BAG16627 529 69
Svu005 400 Streptomyces sp. C ZP_07285089 105D 595 74
Streptomyces avermitilis MA-4680 BAC75180 105D7 529 69
Svh01 399 Streptomyces virginiae ABR68805 105C1 797 99
Streptomyces viridochromogenes DSM 40736 ZP_07307444 105 703 87
Svu006 403 Streptomyces virginiae ABR68807 107 L14 713 99
Streptomyces sp. C ZP_07284721 107 L14 611 87
Svu007 351 Streptomyces sp. C ZP_07290554 107E 609 87
Streptomyces violaceusniger Tu 4113 YP_004815015 540 77
Svu008 406 Streptomyces sp. C ZP_07285026 107 L14 604 77
Streptomyces sp. Mg1 ZP_04997607 107 L14 584 76
Svu009 415 Streptomyces sp. C ZP_07286517 107 L 727 85
Streptomyces sp. Mg1 ZP_04999247 107 L 484 59
Svu010 396 Streptomyces sp. Mg1 ZP_04997607 107 L14 578 74
Streptomyces sp. C ZP_07285026 107 L14 556 72
Svu011 405 Streptomyces sp. C ZP_07287693 107 L 728 91
Streptomyces clavuligerus ATCC 27064 ZP_05005324 107 L 601 75
Svu012 430 Streptomyces sp. C ZP_07287209 107 L 808 92
Streptomyces sp. Mg1 ZP_05000207 107 L 780 91
Svu013 396 Streptomyces sp. C ZP_07287353 107 L 578 75
Streptomyces hygroscopicus subsp. jinggangensis 5008 AEY86095 383 54
Svu014 395 Streptomyces sviceus ATCC 29083 ZP_06921933 107 L 961 80
Streptomyces venezuelae ATCC 10712 CCA53921 107 L 549 79
Svu015 406 Streptomyces sp. Mg1 ZP_05001939 107 L 667 80
Streptomyces scabiei 87.22 YP_003488837 107 L 640 77
Svu016 406 Amycolatopsis editerranei U32 YP_003767608 107 M 482 63
Actinomadura hibisc BAA23153 387 55
Svu017 368 Streptomyces avermitilis MA-4680 NP_823237 197A1 436 64
Streptomyces scabiei 87.22 YP_003487606 389 59
Svu018 393 Streptomyces venezuelae ATCC 10712 CCA55152 121A 509 67
Mycobacterium tuberculosis 02_1987 ZP_06504929 121A 464 57
Svu019 421 Streptomyces sp. C ZP_07287311 124B 782 94
Streptomyces pristinaespiralis ATCC 25486 ZP_06909795 124B 566 70
Svu020 416 Streptomyces sp. C ZP_07289557 147A 731 91
Streptomyces peucetius ATCC 27952 CAE53704 147A 667 79
Svu021 421 Streptomyces sp. C ZP_07290439 152A 515 71
Streptomyces sp. SirexAA-E YP_004806454 152A 429 58
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Table 1 Putative cytochrome P450s in S. virginiae IBL14 with their closest homologs (Continued)
Svu022 412 Streptomyces sp. Mg1 ZP_05002011 154H 742 91
Streptomyces sp. SirexAA-E YP_004804189 154H 666 83
Svu023 409 Streptomyces sp. C ZP_07285064 157A 773 93
Streptomyces sp. Mg1 ZP_05002010 157A 734 88
Svu024 450 Streptomyces sp. Mg1 ZP_05002596 157C 723 82
Streptomyces hygroscopicus ATCC 53653 ZP_07300920 157C 574 64
Svu025 89 Streptomyces tubercidicus AAT45286 185A1 85.9 47
Actinosynnema mirum DSM 43827 YP_003102184 185A 84.7 51
Svu026 409 Streptomyces violaceusniger Tu 4113 YP_004813101 191A 313 44
Rhodococcus opacus B4 YP_002781958 300 43
Svu027 398 Streptomyces sp. C ZP_07286547 191A 756 92
Streptomyces sp. Mg1 ZP_04998169 191A 733 89
Svu028 446 Streptomyces sp. Mg1 ZP_04997583 191A 699 88
Streptomyces sp. C ZP_07290135 191A 692 90
Svu029 476 Singulisphaera acidiphila DSM 18658 ZP_09568426 197A 199 33
Streptomyces roseosporus NRRL 11379 ZP_04712663 197A 191 32
Svu030 447 Streptomyces sp. C ZP_07289871 197B 713 82
Streptomyces sp. Mg1 ZP_05001362 197B 680 77
Svu031 710 Streptomyces sp. C ZP_07284739 197B 353 79
Streptomyces clavuligerus ATCC 27064 ZP_05006237 350 55
Svu032 416 Streptomyces flavogriseus ATCC 33331 YP_004921083 247A 693 81
Frankia alni ACN14a YP_712777 247A 573 70
a The name of the putative CYPs in S. virginiae IBL14.
b Amino acid number of putative CYPs.
c Closest homologs in Genbank and the family classification of CYPs searched in CYPED.
d Number of amino acid overlap, which exceeds the protein size, is due to the introduction of gaps during BLAST comparison.
e The highest percent identity for a set of aligned segments to the same subject sequence.
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which reflects I-helix is not absolutely essential for the
CYP structure. The 2 members of CYP157 family
Svu023 (E276VLW279)/157A and Svu024 (E284QILW288)/
157C do not have arginine residue in K-helix like the
CYP157C1 from S. coelicolor A3(2) having a motif E 297
QSLW [30] and the CYP157A2 and CYP157C2 from S.
avermitilis exhibiting a 257EVLW motif and a 257EQSLW
motif [26]. The CYP157 family proteins that lack con-
sensus EXXR motifs but genetically are linked to their
upstream conservons imply that they have functions
linked to the upstream pathway(s) [30]. Besides, Svu002,
Svu018, Svu021, Svu023 and Svu031 do not strictly fol-
low the GXXXCXG motif of heme-binding.
Multiple alignments and phylogenetic analysis
The phylogenetic tree of the combined CYPs of S.
virginiae IBL14, S. avermitilis MA-4680, S. venezuelae
ATCC 10712 and Streptomyces sp. Mg1 is presented in
Figure 1. From Figure 1, we can find almost of all the
CYPs in S. virginiae IBL14 are closely related to their
homologues. More than 10 of CYPs from S. virginiae
IBL14 are close to those from Streptomyces sp. Mg1 andthe member (Svu001) of new CYP family found in S.
virginiae IBL14 is only close to Streptomyces sp. Mg1.
These results indicate that the CYPs from S. virginiae
IBL14 are closer to those from Streptomyces sp. Mg1 than
those from other Streptomyces spp, including S. avermitilis
MA-4680 and S. venezuelae ATCC 10712. For the four
species of S. virginiae IBL14, sp. Mg1, avermitilis MA-
4680 and S. venezuelae ATCC 10712, the families CYP
107 and CYP157 (labeled with circle A and B in Figure 1,
respectively) have more closely evolutionary relationship.
Further, the paralogous relationship of the 33 CYPs in
S. virginiae IBL14 was generated with the neighbor-
joining methods (Clustal W and MEGA 5.0). From
Figure 2, we can find that svh01 and svu03 and svu04 as
well as svu022 and svu005 in S. virginiae IBL14 have the
closest homologous evolutionary relationship, respect-
ively. It’s worth noting that most members belonging to
the same CYP family are clustered together as expected,
e.g., the 11 members of CYP107 family.
The prediction of functions of CYPs in S. virginiae IBL14
A high identity over 70% among different protein
sequences reasonably suggests that they may hold
Table 2 A comparison of the conserved domain of putative CYPs in S. virginiae IBL14 with those of the same (sub)
family in CYPED using ClustalW
ID I-helix K-helix Heme binding motif Accession numbers
Svu001 Unidentified E335TLR338 F403LPFGAGPRHCVG415 JX119062
Svu002 Unidentified Unidentified L297RVGVDRRLCCG308
Svu003 G276LDTT280 E314LLR317 H375LGFGHGIHQCLG387 JX119063
Svu004 G237HETT241 E275SLR278 H337LGFGHGIHQCLG349 JX119064
Svu005 G247HETT251 E285LMR288 H346LAFGFGIHQCLG358 JX119065
Svh01 G235FDTT239 E273LLR276 H334LAFSHGIHQCLG346 EF646279
Svu006 G277HETT281 E315MLR318 H377IAFGHGLHYCLG389 JX119066
Svu007 G238HETT342 E276LLR279 H339LGFGHGVHHCLG351 JX119067
Svu008 G236HETT240 E275MLR278 H337LAFGHGLHFCIG349 JX119068
Svu009 G236HKTT240 E274MQR277 H338LGFGYGAHYCLG350 JX119069
Svu010 G234HETT238 E273MLR276 H335LAFGHGIHFCIG347 JX119070
Svu011 G242HEAT246 E285LMR288 H346LTFGAGIHYCLG358 JX119071
Svu012 G259FETT263 E302LLR305 H364LGYGHGIHYCLG376 JX119072
Svu013 G237SETV241 E275LFR278 H337LALGHGVHYCLG349 JX119073
Svu014 G234HETT238 E272LLR275 H334LAFGHGVHRCLG346 JX119074
Svu015 F247APTT251 E285VVR288 Q347LSFGIGVHSCLG359 JX119075
Svu016 G244YHTT248 E282ALR285 H345LAFGAGIHFCLG357 JX119076
Svu017 G207FLTT211 E245GLR248 H307VAFGYGPHACPG319 JX119077
Svu018 G231VIST235 E269LLR272 H332FSFGGGSHYCPA344 JX119078
Svu019 G256VETT260 E295MIR298 H356LGFGGGGPHFCLG369 JX119079
Svu020 G251HETT255 E289LLR292 H351LGLGSGIHSCFG363 JX119080
Svu021 T247WFTT251 E281VRR284 E347LIAQGGGNARTGHRCPG364 JX119081
Svu022 G251HETT255 E286TLR289 H349ISFGHGPHVCPG361 JX119082
Svu023 G238HQPT242 E276VLW279 F337SFGHGEHRCPFPA350 JX119083
Svu024 A247FETT251 E284QILW288 S344HLAFSSGPHECPG357 JX119084
Svu025 Unidentified Unidentified H50LALGIGPHVCMG62 JX119085
Svu026 G249NETT253 E287VLR290 H348LALGSGPHYCLG360 JX119086
Svu027 G238NETT242 E274IVR277 H335LGFGGGGPHFCLG348 JX119087
Svu028 G284NDTV288 E322LLR325 H383VSFGDGPHVCLG395 JX119088
Svu029 A242HETT246 E297TLR300 A367FMPFGGGPRTCLG380 JX119089
Svu030 G259HETT263 E314AMR317 A383WFPFGGGPRACIG396 JX119090
Svu031 G499HETT503 E545TLR548 A614YLPFGIGPGPAWARSSRCGS634
Svu032 A252NVTT256 E290GLR293 R351HGAFGFGPHFCIG364 JX119091
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http://www.biomedcentral.com/1471-2164/14/130similar function [26]. As shown in the Table 1, we can
find a sum of 26 CYP sequences of S. virginiae IBL14
have best matches to those of other Streptomyces, which
are helpful in function prediction.
CYP105 and CYP107 are the most studied bacterial
cytochromes which are associated with the degradation
and biotransformation of a diverse array of xenobiotics
and antibiotic biosynthesis. Analysis of CYPs sequence
of S. virginiae IBL14 shows that there are 11 CYPs
belonging to CYP107, five to CYP105, four to CYP197,
three to CYP191, two to CYP157 and one to each otherfamily, which indicates the diversity and importance of
the two groups CYP105 and CYP107. The predicted
functions of several putative CYPs in S. virginiae IBL14,
combined with reported experimental evidences, were
listed in Table 3.
CYPs in S. virginiae IBL14 and their ferredoxin reductase
and ferredoxin
The catalytic activity of CYPs depends greatly on indi-
vidual ferredoxin or/and ferredoxin reductase associated



























































































































































































































































































































































































































































Figure 1 Phylogenetic tree of the CYPs from S. virginiae IBL14 and three related bacteria. Sequences were aligned using Clustal W and the
tree was calculated and constructed using MEGA 5.0. (Streptomyces sp. Mg1, Ssm; S. avermitilis MA-4680, Sam; S. venezuelae ATCC 10712, Sva).
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http://www.biomedcentral.com/1471-2164/14/130ferredoxin reductase genes and six, nine and two
ferredoxin genes in S. coelicolor A3 (2), S. avermitilis
and S. peucetius, respectively. In S. coelicolor A3 (2) only
CYP105D5 is arranged in an operon with a ferredoxin
gene [24]. In S. peucetius CYP147F is clustered with
ferredoxin reductase [27]. In S. avermitilis both
CYP105P1 and CYP105D6 are clustered with ferredoxin,
CYP147B1 is arranged in an operon with a ferredoxin
and ferredoxin reductase, CYP105Q1 is associated in an
operon containing both a ferredoxin and ferredoxin re-
ductase, and CYP102 is fused to a P450 reductase [26].Three ferredoxin reductase genes and seven ferredoxin
genes are found in S. virginiae IBL14 after annotation of
S. virginiae IBL14 genome. That is, the activities of many
of the CYPs in S. virginiae IBL14 are supported by dif-
ferent combinations with the three ferredoxin reductases
and seven ferredoxins. Also in S. virginiae IBL14, svu005
(CYP105D), svh01 (CYP105C) and svu019 (CYP124B) is
found to cluster with ferredoxin svf03, svf09 and svf07,
respectively and svu020 (CYP147A) clustered with
ferredoxin reductase svfr03 and ferredoxins svf06. The



























































































Figure 2 A paralogous tree of all CYP sequences from S. virginae IBL14.
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http://www.biomedcentral.com/1471-2164/14/130Svu005, Svh01, Svu019 and Svu020 needs the participa-
tion of electron transfer. The result of homology analysis
by Blast-searching the Genbank are listed in the Table 4.
Regulatory elements and functional genes clustered with
CYPs
The CYPs in S. peucetius ATCC27952 clustered with regu-
latory elements were reported [27]. In the annotations of
gene arrangement around the putative CYPs on the S.
virginiae IBL14 chromosome, svu022, svu023 and svu024
were found to cluster with the genes of ATP/GTP binding
proteins (having a phosphate-binding loop for energy re-
quiring metabolic reactions) [34], svu001, svu015 to clusterwith LysR-family transcriptional regulator (regulating a di-
verse set of genes, including those involved in virulence,
metabolism, quorum sensing and motility) [35], svu011 to
cluster with two component transcriptional regulators and
LuxR family (quorum sensing signals in Gram-negative
bacteria often regulated by acylated homoserine lactones)
[36], svu018 to cluster with a transcriptional regulator,
AraC family (transcriptional regulators having diverse
functions ranging from carbon metabolism to stress
responses to virulence) [37] and two component transcrip-
tional regulators, LuxR family and svu020 to cluster with
the ATP-binding protein fbpC and TetR-family transcrip-
tional regulators (among bacteria with an HTH DNA-
Table 3 Prediction of functions of several putative CYPs
in S. virginiae IBL14
ID Functions Reference
Svu003 Hydroxylation & O-demethylation [15]
Svu005 N-demethylation & Hydroxylation [31]




Svu021 Hydroxylation& Decarboxylation [33]
Svu022 Hydroxylation& O-dealkylation This study
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efflux pumps, pathways for the biosynthesis of antibiotics,
response to osmotic stress and toxic chemicals, control of
catabolic pathways, differentiation processes, and patho-
genicity) [38].
As described above, the CYPs in S. virginiae IBL14
chromosome are responsible for the transcriptional regu-





Match in the d
Species
Putative ferredoxin reductases
svfr01 JX119052 453 Streptomyces sp.
Streptomyces pri
svfr02 JX119053 463 Streptomyces sp.
Streptomyces sp.
svfr03 JX119054 464 Streptomyces sp.
Streptomyces peu
Putative ferredoxins
svf03 JX119055 219 Streptomyces sp.
Streptomyces viri
svf04 JX119056 1143 Streptomyces sp.
Streptomyces gri
svf05 JX119057 234 Streptomyces sp.
Streptomyces sp.
svf06 JX119058 231 Streptomyces peu
Streptomyces hyg
svf07 JX119059 600 Streptomyces sp.
Streptomyces ven
svf08 JX119060 315 Streptomyces sp.
Streptomyces peu
svf09 JX119061 243 Streptomyces cat
Streptomyces dia
a The name of gene in S. virginiae IBL14.
b Homologues searched in Genbank.secondary metabolism, as well as the responses to envir-
onmental factors as expected. Besides, CYPs are clustered
with other functional genes. svh01 is adjacent to the genes
of MdlB, ABC-type multidrug transport system, ATPase
and permease components, which may be involved in the
transportation of substrates [39]. svu009 lies next to alco-
hol dehydrogenase, suggesting that svu009 may take part
in alcohol bioconversion and biodegradation. svu013 is
next to 4, 5-DOPA dioxygenase which is a member of the
class III extradiol dioxygenase family (a group of enzymes
which use a non-heme Fe (II) to cleave aromatic rings be-
tween a hydroxylated carbon and an adjacent non-
hydroxylated carbon), suggesting that the combination of
svu013 and 4, 5-DOPA dioxygenase may be responsible in
biodegradation of substrates with aromatic rings. svu026 is
adjacent to MbtH-like protein which is found in known
antibiotic synthesis gene clusters [40]. The cholesterol oxi-
dase ChoL from S. virginiae IBL14 in the bioconversion
and biodegradation of diosgenin responsible for the con-
version of diosgenin to diosgenone (a 4-ene-3-keto ster-
oid) via a couple of C3-dehydrogenation and C4-5








cetius ATCC 27952 CAF33360 84
C ZP_07285090 84
dochromogenes DSM 40736 ZP_07308348 79
Mg1 ZP_04996989 83
seoflavus Tu4000 ZP_07315146 83
C ZP_07286537 88
Mg1 ZP_05002165 79
cetius ATCC 27952 ACE73829 62
roscopicus subsp AEY87986 61
C ZP_07287304 98
ezuelae ATCC 10712 CCA56325 94
C ZP_07285869 89
cetius ATCC 27952 ACE73824 88
tleya NRRL 8057 YP_004920089 63
staticus AAR16520 61
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http://www.biomedcentral.com/1471-2164/14/130gene encoding Svu004 (CYP105L) clusters with the genes
of putative ferredoxin Svfr2 and cholesterol oxidase
(ChoL), suggesting that the cytochrome P450 joins with
the cholesterol oxidase ChoL to catalyze the oxidation of
cholesterol and its structural analogs. In conclusion, CYPs
from S. virginiae IBL14 may have multiple functions in
secondary metabolism, including hydroxylation, dehydro-
genation, ring-cleavage, transportation, etc.
Functional identification and characteristics of svh01 and
svu022
To elucidate all putative CYPs’ functions in S. virginiae
IBL14, four CYP genes of the strain IBL14 were firstly
selected. Among them, the functional identities of CYP
genes Svh01(105C1) and svu022 (154H) has been finished.
The cytochrome P450 Svh01 (responsible for the C25-
hydroxylation of diosgenin) [32] belongs to the class I
(prokaryotic/mitochondrial) P450 system based on a taxo-
nomic split, in which electrons are transferred from
NADPH or NADH to ferredoxin reductase and ferredoxin.
Sequence analysis revealed the complete sequence of svh01
with ATG as the start codon has 70% G + C content. The
sequence of possible ribosome-binding site is located on
the upstream of svf09 (a coenzyme of Svh01).
Both svh01 and svf09 contain 1200 bp and 243 bp, re-
spectively, based on sequence analysis. To obtain the
expressed products of them, both svh01 and svf09
sequences were first ligated into a pET22b vector in a
cluster to generate the expression plasmid pET22b-svh01-
svf09 that was then cloned into E. coli JM109 (DE3) to
form a recombinant strain E. coli IBL161 [JM109 (DE3)/
pET22b-svh01-svf09]. The PCR results of svh01 and svf09
from the recombinant strain E. coli IBL161 were analyzed
by gel electrophoresis (Figure 3A and B) and also
confirmed by gene sequencing.
The svu022 with a G + C content of 73% (clustering
with the gene of ATP/GTP binding protein) consists of
1239 nucleotides. Similarly, the complete sequence of
svu022 was first inserted to the shuttle plasmid pHCMC05
to form the recombinant plasmid pHCMC05-svu022, andFigure 3 DNA analysis of svh01, svf09 and svu022 cloned from S. virg
respectively.then cloned in B. subtilis WB800N (improving the extra-
cellular expression level of Svu022 for the analysis of en-
zymatic biotransformation) to produce the recombinant
strain B. subtilis IBL 241 [WB800N/pHCMC05-svu022].
The PCR result of svu022 from the recombinant strain B.
subtilis IBL 241 is shown in Figure 3C.
Svh01 (105C1) is a peptide of 399 amino acids, with a
molecular weight of 44.04 kDa and a pI value of 4.97
estimated by the ExPASy (a computing pI/MW tool).
To obtain its expressed product and study product
characteristics, the recombinant strain E. coli IBL161 was
incubated and induced. The expression of Svh01 was
shown in Figure 4A. From the SDS-PAGE, we can find
that the two distinctly additional protein bands should be
Svh01 with an about MW of 44 kDa and Svf09 with an
about MW of 8.0 kDa, respectively. The further functional
identification of the Svh01/FcpC of S. virginiae IBL14, hy-
droxylating the C25-tertiary carbon of diosgenin to form
isonuatigenone, was experimentally confirmed [32].
Svu022 (154H) is a deduced protein of 412 amino acids
which shares 91% identity with that in Streptomyces sp.
Mg1. The estimation of MW and pI of SVU022 are
44.59 kDa and 5.00, respectively. Similarly, the recombin-
ant strain B. subtilis IBL 241 was incubated and induced
to study the product expression and its characteristics.
The expressed result of Svu022 from the recombinant
strain B. subtilis IBL 241 was shown in Figure 4B. The
SDS-PAGE displays a distinct protein band with about
MW of 45.0 kDa as expected. The further experimental
results from TLC, HPLC and LC/MS indicated that the
CYP Svu022 enables to biotransform β-estradiol into es-
triol. Figure 5 shows the profiles of the biotransformation
of β-estradiol by strains B. subtilis WB800N and B. subtilis
IBL 241 in HPLC. The functional identification of the
Svu005 (CYP105D) and Svu019 (CYP124B) is in progress.
Conclusion
S. virginiae IBL14 contains 33 putative CYPs, 7
ferredoxins and 3 ferredoxin reductases in its 8.0 Mb
linear chromosome. Most of the CYPs in S. virginiaeiniae IBL14. A, B and C are the PCR results of svh01, svf09 and svu022,
Figure 4 SDS-PAGE analysis of Svh01 and Svu022. (A) Lane 1, sample from JM109 (DE3)/pET22b cells; Lane 2, sample from E. coli IBL161. (B)
Lane 1, WB800N/pHCMC05 cells; Lane 2 and 3, B. subtilis IBL 241.
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CYP105 (5 members) family. Compared phylogenetically
with CYPs from 3 typical Streptomycete spp., S. virginiae
IBL14 appears to be closest to those of Streptomyces sp.
Mg1.
Further analysis showed that among all of the 33 CYPs
in S. virginiae IBL14, three CYPs are clustered with
ferredoxins, one with ferredoxin and ferredoxin reduc-
tase and three CYPs with ATP/GTP binding proteins,
four CYPs arranged with transcriptional regulatory genes
and one CYP locates on the upper of ATP-binding pro-
tein and transcriptional regulators as well as four CYPs
associated with other functional genes involved in sec-
ondary metabolism and degradation.Figure 5 The profiles of the transformation of β-estradiol by strain B.
IBL 241; c: standard β-estradiol; d: sample from B. subtilis WB800N.The new characteristics found in CYPs from S. virginiae
IBL14 suggest that the EXXR motif in the K-helix is not
absolutely conserved in CYP157 family as reported [30]
and I-helix not absolutely essential for the CYP structure.
Particularly, one new family was found based on the CYP
svu001 in S. virginiae IBL14 which shares 66% identity
only to that from Streptomyces sp. Mg1.
Two recombinant strains E. coli IBL161 [JM109 (DE3)/
pET22b-svh01-svf09] and B. subtilis IBL 241 [WB800N/
pHCMC05-svu022] were constructed and subsequently
their functions were identified, respectively. Experimental
results showed that both CYP Svh01 and CYP Svu022 are
two hydroxylases, capable of bioconverting diosgenone into
isonuatigenone and β-estradiol into estriol, respectively.subtilis IBL 241 in HPLC. a: standard estriol; b: sample from B. subtilis
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Strains and plasmids
S. virginiae IBL-14 (CCTCCM 206045) [42] as the strain
of interest was used for the Cytochrome P450 gene iden-
tification and functional analysis. E. coli JM109, JM109
(DE3) and B. subtilis WB800N were used as the host for
plasmid construction and target protein expression in
the functional identification of the CYPs, respectively.
The vector pET22b was used for cloning and expression
of genes of interest in E. coli. The shuttle plasmid
pHCMC05 was used for the expression of target
proteins in B. subtilis (a GRAS strain by FDA). The
features of the bacterial strains and plasmids used in this
study are listed in Table 5.
Media and cultivation
Luria-Bertani (LB) medium was used for plasmid con-
struction and protein expression. A final concentration of
70 μg/ml ampicillin was supplemented into the medium
when E. coli IBL161 [JM109 (DE3)/pET22b-svh01-svf09]
and E. coli IBL152 [JM109/pHCMC05-svu022] were
cultivated. A final concentrations of 25 μg/ml chloram-
phenicol was added to the medium when B. subtilis IBL
241 [WB800N/pHCMC05-svu022] was cultivated. The
cultivating procedure of S. virginiae IBL-14 has been
described previously [42]. Diosgenin in 95% purity (J&K
Chemical Ltd, China) and β-estradiol in 98% purity (J&KTable 5 Microorganisms and plasmids used in this study
Strains Relevant properties Source
Escherichia coli
JM109 Cloning host, genotype:endA1, recA1,
gyrA96, thi, hsdR17 (rk–, mk+), relA1,
supE44, (lac-proAB), [F’ traD36, proAB,
laqIqZΔM15]
Promega
JM109 (DE3) Expression host, genotype:endA1,
recA1, gyrA96, thi, hsdR17 (rk–, mk+),
relA1, supE44, λ–, Δ(lac-proAB), [F’,
traD36, proAB, lacIqZΔM15], lDE3
Promega
Bacillus subtilis
WB800N Secretion host with resistance to
neomycin, genotype: nprE aprE epr
bpr mpr :: ble nprB :: bsr vpr wprA ::
hyg cm :: neo; NeoR
Mo Bi Tec
Streptomyces virginiae
IBL14 Wild type Our lab
Plasmids
pET22b Expression vector in E. coli Novagen
pHCMC05 Shuttle plasmid BGSC
pET22b-svh01-svf09 The fragment of svh01 and svf09 were
digested with NdeI/EcoRIand EcoRI/Hind
Ш, respectively, and ligated into the
NdeIand Hind Ш sites of pET22b
This study
pHCMC05-svu022 The gene of svu022 digested with
BamHI/SmaIligated into BamHI/
SmaIdigested pHCMC05
This studyChemical Ltd, China) were dissolved in anhydrous ethanol
before adding into medium.
Sequencing and in-silico identification analyses of CYPs
The S. virginiae IBL14 genome sequencing was
performed at 454 platform (Encode Genomics Co. Ltd.,
Suzhou, China) for the first time (sequence data will be
published step by step). All of the ORFs of this genome
were predicted using glimmer3.0 and prodigal, respect-
ively. To dig out all possible CYP gene function informa-
tion in S. virginiae IBL14, the genome sequence of the
strain was compared with the SWISSPROT, TrEMBL,
KEGG databases by using Blastp and the CDD and COG
databases by using Rpsblast, respectively.
The deduced amino acid sequences of the putative
CYPs of S. virginiae IBL14 were aligned with the CYPs
from S. avermitilis MA-4680, S. venezuelae ATCC 10712
and Streptomyces sp. Mg1 by using ClustalW [43]. Then
the molecular evolution and phylogenetic analyses by
neighbor-joining methods were carried out using
MEGA5.0 [44]. To forecast the possible functions
involved in secondary metabolism, comparison between
all putative CYPs of S. virginiae IBL14 with those in
other organisms based on homologues was done by
using Blastp too.
Using the three motifs as described above as criteria,
the CYP gene candidates of S. virginiae IBL14 were blast
searched against GenBank non-redundant protein data-
base to identify their closest bacterial homologues and
tentatively distribute all of the CYPs of S. virginiae
IBL14 into the corresponding family or subfamily [26].
Similar procedure was performed to the putative
ferredoxin and ferredoxin reductase genes to identify
their closest bacterial homologues.
Construction and cloning of expression plasmids
The genes of svh01, svf09 and svu022 from the genomic
DNA of S. virginiae IBL14 were amplified by using PCR
method (Pfu DNA Polymerase, Fermentas, Thermo Fisher
Scientific Inc.) and the primers used are listed in Table 6.
The PCR products of svh01 and svf09 were digested with
NdeI/EcoRIand EcoRI/Hind III, respectively, then ligatedTable 6 The PCR primers used in this study




pSVF09R CCCAAGCTTTCAGGCGGAGGGTGGGCGG Hind III
pSVU022F CTGGATCCATGAGCTGCCCGATCGACC BamHI
pSVU022R CCTAAGCTTTCAGGGGTGCAGGCGTACCG SmaI
aThe underlined sequence are recognition sites of restriction enzymes and the
nucleotides before it are the protected bases. All primers are designed by
Primer Premier 5.0 and verified by Oligo 7.0.
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bacterium E. coli JM109 (DE3). Similarly, the PCR product
of svu022 was digested with BamHI/Sma I, then ligated
into a shuttle plasmid pHCMC05 and finally transformed
to B. subtilis WB800N.
Expression and analysis of target proteins
0.3 ml (inoculation ratio of 1%) of the overnight culture
of E. coli IBL161 as seed was inoculated in 30 ml LB
medium (containing 70 μg/ml ampicillin) and then
cultivated at a shaking speed of 200 rpm at 37°C. The
expression of target protein was induced by adding
0.2 mM IPTG when the OD value reached 0.5 ~ 0.6 at
600 nm. Then the culture was continuously cultivated
for another 24 h at 25°C at a speed of 200 rpm in a ro-
tary shaker. Similarly, the overnight culture of B. subtilis
IBL 241 was inoculated with 1% ratio in 30 ml LB
medium (25 μg/ml chloramphenicol, 200 rpm at 30°C).
After adding 0.2 mM IPTG in logarithmic growth phase,
the culture was continuously cultivated for another 48 h
at the same conditions. The harvested recombinant cells
were resuspended and subjected to ultrasonication in
50 mM PBS (pH 7.4), and then centrifuged at 6000 rpm
for 5 min. The supernatant was analysed by SDS-PAGE.
Biotransformation and product extraction
One milliliter of β-estradiol/diosgenin (a final concentra-
tion of 0.2 mg/ml) for each flask was added for biotrans-
formation analysis after E. coli IBL161 was induced by
IPTG at 25°C for 2 h. After cultivated for another 24 h
under the same conditions, the cultures were extracted
two times with a half volume of 100% ethyl acetate
(Sinopharm Chemical Reagent Co., Ltd). The extracts
were evaporated to dryness, then re-dissolved in 1 ml
anhydrous ethanol, and finally detected and analyzed
(thin layer chromatography/TLC, high performance li-
quid chromatography/HPLC and liquid chromatog-
raphy–mass spectrometry LC-MS).
DNA and protein analytical methods
DNA electrophoresis for recombinant plasmid analysis
was carried out in agarose gels at 110 V for 30 min [45].
SDS-PAGE with a 15% (w/v) acrylamide gel for
expressed protein analysis was run at 110 V for 2 h
according to Schagger’s publication [46]. The bands were
visualized by Coomassie R-250 staining.
HPLC analysis of biotransformation products
To identify and analyze the metabolites, high perform-
ance liquid chromatography (HPLC) was carried out.
Simply, the sample of 10 μl was first loaded onto
250 mm Symmetry C 18 (4.6 mm × 250 mm, Waters
Co., USA) and eluted with ethanol/water (60/40, v/v).
The flow rate, the wavelength for UV-detection and thetemperature of the column on the HPLC system (Breeze
1525 series, Waters Co., USA) were set at 1 ml/min,
245 nm and 35°C, respectively. The products after bio-
transformation were qualitatively and quantitatively
analyzed by comparing with corresponding standard
material.
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